Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

Similar articles for PubMed (Select 21400232)

1.

First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony-stimulating factor.

Lefrère F, Brignier AC, Elie C, Ribeil JA, Bernimoulin M, Aoun C, Dal Cortivo L, Delarue R, Hermine O, Cavazzana-Calvo M.

Adv Ther. 2011 Apr;28(4):304-10. doi: 10.1007/s12325-011-0009-1. Epub 2011 Mar 10.

PMID:
21400232
3.

Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.

Watanabe H, Watanabe T, Suzuya H, Wakata Y, Kaneko M, Onishi T, Okamoto Y, Abe T, Kawano Y, Kagami S, Takaue Y.

Bone Marrow Transplant. 2006 Apr;37(7):661-8.

PMID:
16489358
4.
5.
6.

GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.

Sohn SK, Kim JG, Seo KW, Chae YS, Jung JT, Suh JS, Lee KB.

Bone Marrow Transplant. 2002 Jul;30(2):81-6.

8.

Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patients.

Kolbe K, Peschel C, Rupilius B, Després D, Burger K, Sklenar I, Färber L, Huber C, Derigs HG.

Bone Marrow Transplant. 1997 Dec;20(12):1027-32.

9.

Successful peripheral blood stem cell harvesting with granulocyte colony-stimulating factor alone after previous mobilization failure.

Lefrère F, Lévy V, Makke J, Audat F, Cavazzana-Calvo M, Micléa JM.

Haematologica. 2004 Dec;89(12):1532-4.

10.

Comparison of lenograstim vs filgrastim administration following chemotherapy for peripheral blood stem cell (PBSC) collection: a retrospective study of 126 patients.

Lefrère F, Bernard M, Audat F, Cavazzana-Calvo M, Belanger C, Hermine O, Arnulf B, Buzyn A, Varet B.

Leuk Lymphoma. 1999 Nov;35(5-6):501-5.

PMID:
10609787
11.

Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation.

Narayanasami U, Kanteti R, Morelli J, Klekar A, Al-Olama A, Keating C, O'Connor C, Berkman E, Erban JK, Sprague KA, Miller KB, Schenkein DP.

Blood. 2001 Oct 1;98(7):2059-64.

12.

Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.

Wang S, Nademanee A, Qian D, Dagis A, Park HS, Fridey J, Smith E, Snyder D, Somlo G, Stein A, Rosenthal J, Falk P, Kogut N, Palmer J, Gaal K, Kim Y, Bhatia R, Yuan S, Kay C, Weiss L, Forman S.

Transfusion. 2007 Dec;47(12):2207-16. Epub 2007 Aug 21.

PMID:
17714420
13.

Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers.

Goterris R, Hernández-Boluda JC, Teruel A, Gómez C, Lis MJ, Terol MJ, Tormo M, Solano C, Arbona C.

Bone Marrow Transplant. 2005 Nov;36(10):847-53.

PMID:
16113660
14.

Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma.

Nakasone H, Kanda Y, Ueda T, Matsumoto K, Shimizu N, Minami J, Sakai R, Hagihara M, Yokota A, Oshima K, Tsukada Y, Tachibana T, Nakaseko C, Fujisawa S, Yano S, Fujita H, Takahashi S, Kanamori H, Okamoto S; Kanto Study Group of Cell Therapy.

Am J Hematol. 2009 Dec;84(12):809-14. doi: 10.1002/ajh.21552.

PMID:
19862826
15.

A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.

Lefrère F, Zohar S, Bresson JL, Chevret S, Mogenet A, Audat F, Durand-Zaleski I, Ghez D, Dal Cortivo L, Piesvaux P, Cavazzana-Calvo M, Varet B.

Haematologica. 2006 Apr;91(4):550-3.

16.

Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.

Damon L, Rugo H, Tolaney S, Navarro W, Martin T 3rd, Ries C, Case D, Ault K, Linker C.

Biol Blood Marrow Transplant. 2006 Mar;12(3):316-24.

17.

Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.

Benboubker L, Cartron G, Roingeard F, Delain M, Degenne M, Linassier C, Hérault O, Truglio D, Bout M, Petit A, Brémond JL, Desbois I, Colombat P, Binet C, Domenech J.

Exp Hematol. 2003 Jan;31(1):89-97.

PMID:
12543111
18.

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.

Burns LJ, Weisdorf DJ, DeFor TE, Repka TL, Ogle KM, Hummer C, Miller JS.

Exp Hematol. 2000 Jan;28(1):96-103. Erratum in: Exp Hematol. 2000 Mar;28(3):347.

PMID:
10658681
19.

High CD8+ lymphocyte dose in the autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation.

Atta EH, de Azevedo AM, Maiolino A, Coelho CJ, Sarcinelli SM, de Alvarenga Máximo C, Marra VL.

Am J Hematol. 2009 Jan;84(1):21-8. doi: 10.1002/ajh.21314.

PMID:
19006229
20.

Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.

Gajewski JL, Rondon G, Donato ML, Anderlini P, Korbling M, Ippoliti C, Benyunes M, Miller LL, LaTemple D, Jones D, Ashby M, Hellmann S, Durett A, Lauppe J, Geisler D, Khouri IF, Giralt SA, Andersson B, Ueno NT, Champlin R.

Biol Blood Marrow Transplant. 2002;8(10):550-6.

PMID:
12434950
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk